Arca
Skip to content
Tools
Tools

Locoid (hydrocortisone butyrate 0.1%)

Recall D-0026-2015, part of FDA recall event 69359. See Valeant Pharmaceuticals International's company page.

Valeant Pharmaceuticals International started this Class III drug recall on Oct 2, 2014 (voluntary: firm initiated); FDA lists it as terminated, terminated Apr 3, 2015.

  • Classification: Class III
  • Started: Oct 2, 2014
  • Status: Terminated
  • Products in this event: 2

Why It Was Recalled

Class III

Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point

Record

Product
Locoid (hydrocortisone butyrate 0.1%), Cream, Net Wt. 15 gm tubes, Rx only, Manufactured for: Onset Dermatologics, LLC, Cumberland, RI 02864 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 16781-382-15
Quantity
1663 tubes
Lots and codes
Lot number 13052B, Exp. 03/2015, NDC16781-382-15
Distribution
Nationwide and Puerto Rico
Recalling firm
Valeant Pharmaceuticals International, Bridgewater, NJ, United States
How the firm notified
Letter
FDA classified
Oct 16, 2014

Other Products in This Recall

Recall event 69359

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.